AC Immune S.A. (NQ: ACIU )

6.500 USD -0.030 (-0.46%)

Streaming Delayed Price Updated: 9:37 AM EST, Jan 26, 2021 Add to My Watchlist

Price and Volume

Volume	38,025
Open	6.520
Bid (Size)	6.460 (1)
Ask (Size)	6.540 (10)
Prev. Close	6.530
Today's Range	6.500 - 6.600
52wk Range	4.070 - 13.00
Shares Outstanding	57,362,690
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay

December 15, 2020

Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors

November 20, 2020

Performance

YTD	+22.18%	+22.18%
1 Month	+21.27%	+21.27%
3 Month	+34.02%	+34.02%
6 Month	-11.68%	-11.68%
1 Year	-25.37%	-25.37%

More News

Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer

November 18, 2020

AC Immune Reports Q3 2020 Financial Results and Provides Business Update

November 13, 2020

AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference

November 12, 2020

AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development

November 09, 2020

Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer

October 13, 2020

Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent

October 09, 2020

AC Immune (ACIU) Shares Cross Above 200 DMA

January 11, 2021

AC Immune: Q3 Earnings Insights

November 13, 2020

The Math Shows IBB Can Go To $170

November 12, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.